Julphar Targets Double-Digit Growth In 2018

date

06-Mar-2018

Ras Al Khaimah, United Arab Emirates,6March2018, (AETOSWire):Julphar reviewed non-audited preliminary financial results for 2017 and forecasts for 2018, following its Board of Directors’ meeting, which was chaired by His Highness Sheikh Faisal Bin Saqr Al Qasimi, Chairman of the Board of Julphar. Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, recorded sales of AED 1.3 billion for the year ending December 31, 2017, despite the challenging and rapidly changing market environment. Julphar’s General Manager, Jerome Carle, said, “Firstly, I wish to express my gratitude to the shareholders, colleagues, customers, partners and all the stakeholders of the company for their continued support. In 2017, Julphar faced major challenges, such as currency headwinds, forex shortage, political instability and price cuts. “However, key milestones have been achieved, including the official opening of our plant in Saudi Arabia, our entry into three highly important markets with large populations – Mexico, Uzbekistan and Sri Lanka – not to mention being ranked number one in the UAE for the first time. We also registered 130 new products last year and signed an important agreement with the Ministry of Health in the UAE to ensure the availability of critical medical supplies during crisis situations.” “We are off to a solid start in 2018, as evidenced by the successful acquisition of Gulf Inject, new distribution agreements in Africa and Asia, all of which indicate a healthy outlook for the business. We are building up a solid pipeline and we are targeting double-digit growth in 2018 with the planned launches of 25 new products in UAE. “We aim to increase our impact in the global pharmaceutical industry by enhancing our operations in emerging markets and increasing our presence in Africa.” In 2017, Julphar opened a manufacturing facility in Jeddah, Saudi Arabia adding to its overseas production bases in Ethiopia and Bangladesh. The SAR 300 million state-of-the-art plant has the capacity to produce 1 billion tablets, 300 million capsules and 30 million bottles of syrups and suspensions per year.- Earlier this month, Julphar Saudi Arabia was granted Current Good Manufacturing Practice (cGMP) approval by the Saudi Food and Drug Authority (SFDA).
About Julphar Julphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa, was established in 1980 under the guidance of His Highness Sheikh Saqr Bin Mohammed Al Qasimi. The company employs 5,000 people and distributes a wide range of products to more than 50 countries on five continents across the globe. Julphar’s business is centered on three core units – Diabetes Solutions, General Medicines, and its consumer division, Julphar Life. The company’s vast product portfolio target major therapeutic segments including Family Care, Gastrology, Pain and Wound Management, Antibiotic, Cardiovascular and Metabolism. Julphar has 16 internationally accredited facilities in Africa, Middle East and Asia that produce more than a million boxes of medicines a day including tablets, syrups, suspensions, creams and injectables. In 2012, Julphar became one of the largest producer of Insulin with its UAE-based Biotechnology production unit.
 

Latest Press Releases

Iconic Handset Features the Flagship Kirin 990 5G SoC!

..

22-Sep-2019

The Award was designed and developed to recognise exceptional work globally

..

22-Sep-2019

Unveiling Full Agenda Tomorrow (Monday)

..

22-Sep-2019

Sell with The Luxury Closet at their upcoming events

..

19-Sep-2019

Love, Beauty and Planet aims to reduce its carbon footprint by 20 per cent

..

16-Sep-2019

Aims to achieve goals of Agenda 2030 for sustainable development in the Arab region

..

22-Sep-2019


Most Viewed Recent Press Releases

Vistara, India’s finest full-service carrier and a JV of Tata and Singapore Airlines, yesterday inaugurated ...

[2982 views]

Contentious Subject of Very Low Carb Diets was Chosen as the Topic for Debate at Imperial College London ...

[2718 views]

Shaza Hotels has announced the opening of the highly anticipated Al Badayer Oasis – Sharjah Collection ...

[2685 views]

The author interacted with the youth, shared copies of her latest novel, and talked about the intricacies ...

[2601 views]

As part of Dubai Judicial Institute’s (DJI) efforts to support the Dubai Strategy for the People of ...

[2511 views]

Moorfields endorses taking precautions to get the most out of the season while decreasing any risk

[2496 views]


Related Links_


Google ADS

Other Info_

..

Health Care

Multi Specialty medical facilities, government hospitals & private clinics

..

Education

Nurseries, Kindergardens, Schools, Colleges, Universities & Higher Education

..

Popular Restaurants

Dining in Dubai - selection of restaurants where you can relax & enjoy a variety of cuisines of choice

Jobs at Dubai_

Find latest Dubai Jobs & Vacancies from placement agencies, employers & recruitment consultants in Dubai, Abu Dhabi & other Emirates in UAE.

Dubai Tours & Packages_

Book quality Dubai tours, best Dubai holiday packages with visas & Dubai hotel booking with special offers & discounts

Warnning

Unsupported Browser

This website includes CSS elements that your browser does not support. Please upgrade your browser to a current version, then come back and try again.

Upgrade your Browser for more experience

Chrome Firefox Safari Edge